Safety and efficacy of Alternating mFOLFOX6 and FOLFIRI every 4cycles as First line Therapy in Advanced colorectal Cancer

ABSTRACT: Interventions: Alternating mFOLFOX6 and FOLFIRI every 4cycles. Primary outcome(s): RR Study Design: Single arm Non-randomized

DISEASE(S): Unresectable Advanced/recurrent Colorectal Cancer

PROVIDER: 2616832 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR